Latest News
Throgmorton, one of the UK’s largest specialist accountancy and professional services providers to the hedge fund, private equity and corporate finance industries, has hired Sara Selvarajah to bolster its tax team.
Selvarajah will assist and service Throgmorton’s increasing client base with her knowledge across all aspects of tax. The firm hopes to capitalise on the shrinking banking sector and the growing number of proprietary trading desks spinning out to set up fund management companies. Selvarajah’s significant experience and contacts within the banking sector will help achieve this.
Formally a senior member of the tax team at Salomon Brothers and
Ogier Cayman’s litigation team has promoted both Shaun Folpp and Rachael Reynolds to Managing Associates, and Michael Makridakis to Senior Associate. These appointments reflect the contributions of these individuals to Ogier’s litigation practice over the past 18 months.
Ogier Fiduciary Services Cayman Limited meanwhile, has promoted Scott Dakers to Director. In his new role, Dakers will focus on ensuring the highest quality of services targeted to clients in the investment funds sector as well as corporate and commercial.
“These promotions reflect the outstanding contributions these individuals have made in their respective areas of expertise,” says Peter Cockhill, Managing Partner,
ConnectAndSell, a provider of on-demand telephone conversations with prospects and customers, has closed aUSD$7.5 million later-stage round of financing led by Institutional Venture Partners (IVP).
In conjunction with the financing, Steve Harrick, General Partner of IVP, has joined Mike Maples Jr, Managing Partner of Floodgate, on the company’s Board of Directors. Floodgate is the original seed investor in ConnectAndSell.
ConnectAndSell provides Live Conversation Automation solutions, using disruptive technology to dramatically increase the number of live telephone conversations sales representatives can have per hour. The company’s solution combines proprietary software with outsourced call centres to substantially improve the connect rate. ConnectAndSell customers
August & Debouzy advised François Sarkozy, Yannick Sabatin and their respective consulting firms, FSNB Conseil and YS Conseil, on the sale of the entire share capital of Healthcare Consulting – which has now become Publicis Healthcare Consulting – to the Publicis Group.
Publicis Healthcare Consulting is a strategy, organisation and management consulting firm for industrial operators in the health sector, headquartered in Paris and with an office in New York. Publicis Healthcare Consulting will continue to be led by its founders, François Sarkozy and Yannick Sabatin.
August & Debouzy’s teams, led by Gilles August, partner in the firm’s corporate department,
Kohlberg Kravis Roberts & Co has appointed Steven R Okun as Director of Public Affairs in Asia Pacific, effective 13 February 2011. Okun will be responsible for overseeing the firm’s public affairs, corporate citizenship and external communications in Asia Pacific, as well as for helping to support the public affairs and communications efforts of KKR’s portfolio companies in the region.
Okun, who currently serves as Chairman of the American Chamber of Commerce in Singapore, and until October 2010, was Vice President for Public Affairs for UPS in Asia Pacific, will report to Kenneth B Mehlman, Member and Global Head of
Phase4 Ventures, the Life Science venture capital business of Nomura, has been acquired by its management team, and a significant portion of its assets under management have been sold to funds managed by HarbourVest Partners LLC.
Dr Denise Pollard-Knight (pictured), Managing Partner of Phase4 Ventures, says: “We are delighted to have HarbourVest as our new partner as we move forward as an independent venture capital firm with the team that built this business for the past decade from within Nomura. This transaction achieves the objectives of all the parties involved, allows us to continue supporting our portfolio companies whilst
Graphite Capital, a UK mid-market private equity specialist, has added to its team with the appointment of Simon May (pictured) as investment manager.
May joins Graphite after six years at PwC, most recently as a manager in the Business Recovery Services division where he focused on the manufacturing, distribution and healthcare sectors. He is a chartered accountant and holds a first class degree in mathematics from the University of Bath. As well as working with portfolio companies, May will look at investment opportunities and specifically cover the Midlands region.
Rod Richards, Graphite managing partner, says: “We are delighted to welcome
Global Capital Management’s Global Buyout Fund has successfully acquired 80% of Bıçakcılar Tıbbi Cihazlar AŞ and its group of companies (Bıçakcılar), the leading manufacturer of medical equipment and disposables, and distributor of cardiovascular and neurosurgery products in Turkey.
The agreement was signed by Ferhat Bıçakcı representing the owners, Bıçakcı Family and Ihsan Sancay, Partner at Global Capital Management in Turkey representing the Global Buyout Fund.
Bıçakcılar enjoys dominant market position in most of its product lines. It is the largest manufacturer of IV cannula in the Middle East and Eastern Europe and is the second largest manufacturer of
Cayman Finance Chairman Anthony Travers, OBE has stepped down from his post after two years in office.
According to Cayman Finance, Travers want to spend more time attending to his other business ventures and with his family. During this transitional period, the remaining board members will share directional responsibilities, and an interim Chairman is expected to be announced imminently. Further announcements will be made in due course.
“I was asked to take on the role at a time when our public relations were at a low ebb," says Travers. "At the time the UK and US Governments were extremely hostile to the Cayman
Ulthera, developer of the first-ever ultrasound device approved by the FDA for aesthetics, announced today the recent completion of USD10.5 million in Series C venture funding. The funding was led by New Enterprise Associates (NEA) with participation by funds managed by Apposite Capital LLP.
"Ulthera’s growth has been truly impressive, especially since receiving FDA clearance in late 2009," says Justin Klein, MD, Principal at New Enterprise Associates and Ulthera board member. "NEA looks to invest in companies that bring highly differentiated technologies to meet the needs of medical professionals and consumers, and we are enthusiastic about Ulthera’s future prospects. We
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
